Skip to main content
. 2020 Oct 21;40(12):2906–2916. doi: 10.1111/liv.14696

TABLE 2.

Overview of studies investigating intestinal permeability using serum zonulin

Author, Country Adult Children NAFLD Method NAFLD HC Method HC IP test Main outcome
Loffredo et al 2017, Italy 39 Children

67 NAFLD

‐ 44NAFL

‐ 23 NASH

Biopsy

NAS 1‐4

NAS ≥ 5

72 HC Not specified Serum zonulin

‐ zonulin ↑ in NAFLD vs HC (P = .0001)

‐ Zonulin = in NASH vs NAFL (P = .10)

Cakir et al 2017, Turkey 40 Children 28 NAFLD US 30 HC Not specified Serum zonulin Zonulin ↑ in NAFLD vs HC (P = .049)
Pacifico et al 2014, Italy 14 Children

40 NAFLD

‐ 15 NAFL

‐ 25 NASH

Biopsy

NAS

NASb

40 HC a MRI Serum zonulin Zonulin ↑ in NAFLD vs HC (P = .009)
Hendy et al 2017, Egypt 22 Adult

56 NAFLD

‐ 24 NAFL

‐ 32 NASH

Biopsy

NAS 1‐4

NAS ≥ 5

20 HC a Biopsy Serum zonulin

‐ zonulin ↑ in NAFLD vs HC (P < .001)

‐ zonulin ↑ in NASH vs NAFL (P < .001)

Chwist et al 2014, Poland 13 Adult

70 NAFLD

‐ 43 NAFL

‐ 27 NASH

Biopsy

NAS 1‐4

NAS ≥ 5

NP NP Serum zonulin zonulin ↑ in NASH vs NAFL (P = .003)

Abbreviations: NP, not present; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; NAFL, simple steatosis; HC, healthy control; US, ultrasound; IP, intestinal permeability; NAS, NAFLD activity score.

a

BMI not significantly different between HC vs NAFLD.

b

Diagnosis based on NAS. All patients with NASH had minimal: steatosis (1‐3), lobular inflammation (1‐3) and ballooning (1‐2).